SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
17960771
Source:
http://linkedlifedata.com/resource/pubmed/id/17960771
Search
Subject
(
40
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0007131
,
umls-concept:C0030705
,
umls-concept:C0038952
,
umls-concept:C0205179
,
umls-concept:C0282461
,
umls-concept:C0332185
,
umls-concept:C1883256
pubmed:issue
11
pubmed:dateCreated
2007-11-26
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/17960771-17285602
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/0374236
pubmed:citationSubset
AIM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
0008-543X
pubmed:author
pubmed-author:BearzAlessandraA
,
pubmed-author:BerrettaMassimilianoM
,
pubmed-author:FratinoLuciaL
,
pubmed-author:SerrainoDiegoD
,
pubmed-author:TirelliUmbertoU
pubmed:issnType
Print
pubmed:day
1
pubmed:volume
110
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
2593-4; author reply 2594
pubmed:meshHeading
pubmed-meshheading:17960771-Antineoplastic Agents
,
pubmed-meshheading:17960771-Carcinoma, Non-Small-Cell Lung
,
pubmed-meshheading:17960771-Clinical Trials, Phase III as Topic
,
pubmed-meshheading:17960771-Humans
,
pubmed-meshheading:17960771-Lung Neoplasms
,
pubmed-meshheading:17960771-Survival Analysis
,
pubmed-meshheading:17960771-Survival Rate
pubmed:year
2007
pubmed:articleTitle
Recent improvement in the survival of patients with advanced nonsmall cell lung cancer enrolled in phase III trials of first-line, systemic chemotherapy.
pubmed:publicationType
Letter
,
Comment